Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Mycobacterium abscessus complex

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Inhaled granulocyte–macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis
Nontuberculous mycobacteria (NTM) are an important emerging threat to cystic fibrosis (CF) patients. In North America where the… Expand
Is this relevant?
Review
2018
Review
2018
Treatment of Mycobacterium abscessus Complex
&NA; Of the nontuberculous mycobacteria (NTMs) causing lung disease, members of the Mycobacterium abscessus complex (MABc… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2017
2017
In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
Macrolides, especially clarithromycin (CLA), remain the cornerstone of therapy for Mycobacterium abscessus complex infections… Expand
  • table 1
  • table 2
Is this relevant?
2017
2017
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
OBJECTIVES The differentiation between Mycobacterium abscessus subspecies abscessus (M. abscessus) and Mycobacterium abscessus… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2016
Review
2016
Nontuberculous Mycobacteria in Cystic Fibrosis
Opinion statementNontuberculous mycobacteria (NTM) are found in approximately 10 % of cystic fibrosis (CF) patients, but only a… Expand
  • table 1
  • figure 1
Is this relevant?
2015
2015
Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis.
Early signs of pulmonary disease with Mycobacterium abscessus complex (MABSC) can be missed in patients with cystic fibrosis (CF… Expand
Is this relevant?
2015
2015
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia
BACKGROUND Nontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patients but their epidemiology is… Expand
  • figure 1
  • figure 2
  • table 2
  • table 1
  • table 3
Is this relevant?
2014
2014
Importance of Reciprocal Balance of T Cell Immunity in Mycobacterium abscessus Complex Lung Disease
BACKGROUND Little is known about the nature of the host immune response to Mycobacterium abscessus complex (MABC) infection. The… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2013
2013
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations.
BACKGROUND Clinical observations suggest that Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex (MABSC) may… Expand
Is this relevant?
2013
2013
Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.
Cystic fibrosis (CF) patients are at particularly high risk of developing lung disease caused by Mycobacterium abscessus complex… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE